Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
Abstract Background The global COVID-19 vaccination campaign, with 13.53 billion doses administered by early 2024, has significantly reduced severe illness and mortality. However, potential adverse effects, such as Postural Orthostatic Tachycardia Syndrome (POTS), have raised concerns. This systemat...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2024-11-01
|
| Edice: | BMC Cardiovascular Disorders |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12872-024-04315-x |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
